Fundraising Fox
/Companies
Sign in

MDxHealth

Herstal, US · Founded 2003 · 317 employees on LinkedIn · 2 known investors

Find your way into MDxHealth

Each arrow is one introduction. Sign up to fill in the first one.

605 people can intro you to Wim

Ask Roel Bulthuis to introduce you to Wim Van Criekinge

You →Roel · together at Devgen →Wim

175 people can intro you to Ron

Ask Jamie Chen to introduce you to Ron Kalfus

You →Jamie · together at Cherry Bekaert →Ron

37 people can intro you to John

Ask Sam Okafor to introduce you to John Bellano

You →Sam · together at AssureRx Health, Inc →John

Sign up to find every way you can get introduced to MDxHealth

  • Your email: who you already know at MDxHealth, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MDxHealth team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

JBJohn Bellano
John BellanoChief Commercial OfficerJohn Bellano held commercial leadership roles in diagnostics and precision medicine, including scaling Assurex Health from $700K to over $100M in revenue before its $410M acquisition by Myriad Genetics, and leading commercial operations at MDxHealth through revenue growth from $11.7M to over $140M. He has managed P&L budgets exceeding $30M, led organizations of 200+ commercial professionals, and guided two companies through IPO processes.
RKRon Kalfus
Ron KalfusCFORon Kalfus is a CPA who has held CFO positions at public and private equity-backed life sciences and healthcare companies, with experience in NASDAQ IPOs, SEC compliance, and mergers and acquisitions exceeding $100 million in value.
JSJoseph Sollee
Joseph SolleeExecutive
WVWim Van Criekinge
Wim Van CriekingeChief Scientific OfficerWim Van Criekinge is Chief Scientific Officer at MDxHealth and a part-time professor at UGent, where he heads the computational genomics and bioinformatics laboratory. He co-founded Devgen, a biotechnology company that went public in 2005, and has consulted for biotech, pharmaceutical, and agricultural firms.
MM
Michael McGarrityChief Executive Officer & Executive Director
CS
Christian SolleeExecutive Vice President of Corporate Development and General Counsel

Board

JP
Jan PensaertPermanent representative of Valiance Advisors LLP.
DM
Donnie M. Hardison Jr.Board director
RS
Regine SlagmulderPermanent representative of Regine Slagmulder BV.
LV
Lieve VerplanckePermanent representative of Qaly-Co BV.
HW
Hilde WindelsPermanent representative of Hilde Windels BV.
KH
Koen HoffmanPermanent representative of Ahok BV.

Investors · 2

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$25M disclosed across 2 rounds · 2022–2026

  • $20Mdirect share offeringAug 2026 · 2 sources
    Source ↗
▶$5MraisedAug 2022 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John BellanoExecutive Officer
  • Donnie M. Hardison Jr.Director
  • Regine SlagmulderDirector
  • Michael K. McGarrityExecutive Officer, Director
  • Lieve VerplanckeDirector
  • Hilde WindelsDirector
  • Koen HoffmanDirector
  • Jan PensaertDirector
  • Ron KalfusExecutive Officer
  • Joseph SolleeExecutive Officer
  • Eric BednarskiDirector
Amount sold
$5M
First sale
Aug 2022
Incorporated
Corporation, Belgium
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does MDxHealth do?
MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
Who are MDxHealth's investors?
MDxHealth's investors include Andera Partners, OrbiMed.
How much funding has MDxHealth raised?
MDxHealth has disclosed $25M raised across 2 rounds.
Where is MDxHealth headquartered?
MDxHealth is headquartered in Herstal, US.